FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909218971> ?p ?o ?g. }

• W2909218971 endingPage "442" @default.
• W2909218971 startingPage "428" @default.
• W2909218971 abstract "Abstract In cancers with tumor-infiltrating lymphocytes (TILs), monoclonal antibodies (mAbs) that block immune checkpoints such as CTLA-4 and PD-1/PD-L1 promote antitumor T-cell immunity. Unfortunately, most cancers fail to respond to single-agent immunotherapies. T regulatory cells, myeloid derived suppressor cells (MDSCs), and extensive stromal networks within the tumor microenvironment (TME) dampen antitumor immune responses by preventing T-cell infiltration and/or activation. Few studies have explored combinations of immune-checkpoint antibodies that target multiple suppressive cell populations within the TME, and fewer have studied the combinations of both agonist and antagonist mAbs on changes within the TME. Here, we test the hypothesis that combining a T-cell–inducing vaccine with both a PD-1 antagonist and CD40 agonist mAbs (triple therapy) will induce T-cell priming and TIL activation in mouse models of nonimmunogenic solid malignancies. In an orthotopic breast cancer model and both subcutaneous and metastatic pancreatic cancer mouse models, only triple therapy was able to eradicate most tumors. The survival benefit was accompanied by significant tumor infiltration of IFNγ-, Granzyme B-, and TNFα-secreting effector T cells. Further characterization of immune populations was carried out by high-dimensional flow-cytometric clustering analysis and visualized by t-distributed stochastic neighbor embedding (t-SNE). Triple therapy also resulted in increased infiltration of dendritic cells, maturation of antigen-presenting cells, and a significant decrease in granulocytic MDSCs. These studies reveal that combination CD40 agonist and PD-1 antagonist mAbs reprogram immune resistant tumors in favor of antitumor immunity." @default.
• W2909218971 created "2019-01-25" @default.
• W2909218971 creator A5001768193 @default.
• W2909218971 creator A5024136222 @default.
• W2909218971 creator A5034534872 @default.
• W2909218971 creator A5036018104 @default.
• W2909218971 creator A5040397625 @default.
• W2909218971 creator A5040720823 @default.
• W2909218971 creator A5050642902 @default.
• W2909218971 creator A5054895913 @default.
• W2909218971 creator A5063962225 @default.
• W2909218971 creator A5065082036 @default.
• W2909218971 creator A5068401950 @default.
• W2909218971 creator A5085518364 @default.
• W2909218971 date "2019-03-01" @default.
• W2909218971 modified "2023-10-17" @default.
• W2909218971 title "A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity" @default.
• W2909218971 cites W1483682701 @default.
• W2909218971 cites W1598422965 @default.
• W2909218971 cites W1621615533 @default.
• W2909218971 cites W1631320694 @default.
• W2909218971 cites W1973087765 @default.
• W2909218971 cites W1976199086 @default.
• W2909218971 cites W1980437273 @default.
• W2909218971 cites W1982093899 @default.
• W2909218971 cites W1988877663 @default.
• W2909218971 cites W1993659680 @default.
• W2909218971 cites W1996145004 @default.
• W2909218971 cites W2004619271 @default.
• W2909218971 cites W2010709305 @default.
• W2909218971 cites W2032166347 @default.
• W2909218971 cites W2035686689 @default.
• W2909218971 cites W2043991982 @default.
• W2909218971 cites W2051122657 @default.
• W2909218971 cites W2057377546 @default.
• W2909218971 cites W2060070314 @default.
• W2909218971 cites W2068994108 @default.
• W2909218971 cites W2071483270 @default.
• W2909218971 cites W2071882245 @default.
• W2909218971 cites W2076956606 @default.
• W2909218971 cites W2082345666 @default.
• W2909218971 cites W2086526310 @default.
• W2909218971 cites W2100519108 @default.
• W2909218971 cites W2102332546 @default.
• W2909218971 cites W2102886314 @default.
• W2909218971 cites W2105910061 @default.
• W2909218971 cites W2107079238 @default.
• W2909218971 cites W2108712362 @default.
• W2909218971 cites W2109044040 @default.
• W2909218971 cites W2112121482 @default.
• W2909218971 cites W2112853593 @default.
• W2909218971 cites W2112855928 @default.
• W2909218971 cites W2113657892 @default.
• W2909218971 cites W2116495352 @default.
• W2909218971 cites W2117552772 @default.
• W2909218971 cites W2118546263 @default.
• W2909218971 cites W2119895292 @default.
• W2909218971 cites W2128035403 @default.
• W2909218971 cites W2131811425 @default.
• W2909218971 cites W2132290857 @default.
• W2909218971 cites W2134303311 @default.
• W2909218971 cites W2149366474 @default.
• W2909218971 cites W2149639357 @default.
• W2909218971 cites W2153935963 @default.
• W2909218971 cites W2154506633 @default.
• W2909218971 cites W2159116335 @default.
• W2909218971 cites W2160834915 @default.
• W2909218971 cites W2161558877 @default.
• W2909218971 cites W2166662937 @default.
• W2909218971 cites W2169410102 @default.
• W2909218971 cites W2170584525 @default.
• W2909218971 cites W2212433271 @default.
• W2909218971 cites W2291366206 @default.
• W2909218971 cites W2295620064 @default.
• W2909218971 cites W2320605421 @default.
• W2909218971 cites W2324865626 @default.
• W2909218971 cites W2460994064 @default.
• W2909218971 cites W2461271870 @default.
• W2909218971 cites W2537734913 @default.
• W2909218971 cites W2560367415 @default.
• W2909218971 cites W2572174216 @default.
• W2909218971 cites W2604591951 @default.
• W2909218971 cites W2767993459 @default.
• W2909218971 cites W2914587369 @default.
• W2909218971 cites W4210637293 @default.
• W2909218971 doi "https://doi.org/10.1158/2326-6066.cir-18-0061" @default.
• W2909218971 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6397686" @default.
• W2909218971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30642833" @default.
• W2909218971 hasPublicationYear "2019" @default.
• W2909218971 type Work @default.
• W2909218971 sameAs 2909218971 @default.
• W2909218971 citedByCount "89" @default.
• W2909218971 countsByYear W29092189712019 @default.
• W2909218971 countsByYear W29092189712020 @default.
• W2909218971 countsByYear W29092189712021 @default.
• W2909218971 countsByYear W29092189712022 @default.
• W2909218971 countsByYear W29092189712023 @default.
• W2909218971 crossrefType "journal-article" @default.

• next